Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use OXERVATE safely and effectively. See full prescribing information for OXERVATE. OXERVATE® (cenegermin-bkbj) ophthalmic solution, for topical ophthalmic useInitial U.S. Approval: 2018
Medication labelWhy this: Advisory · dailymed-prescription
OXERVATE® (cenegermin-bkbj) ophthalmic solution 0.002% is indicated for the treatment of neurotrophic keratitis.
- generic_name
- cenegermin-bkbj
- product_names
- cenegermin-bkbj
- ndc
- 71981-020, 71981-020-07, 71981-001, 71981-001-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en